Stay updated on IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.

Latest updates to the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page
- Check3 days agoChange DetectedNew revision v3.6.6 is added to the history, replacing the previous v3.6.5 entry. This reflects an update to the record's version without altering the underlying study data or public-facing content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page’s revision label updated from v3.6.4 to v3.6.5, indicating a new platform version. No changes to study content or metadata are indicated by this update.SummaryDifference0.1%

- Check38 days agoChange DetectedA new revision entry v3.6.4 was added to the record history, replacing the previous v3.6.3. This indicates an update to the study record’s versioning details rather than changes to the study content.SummaryDifference0.1%

- Check67 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.3, indicating a new release state of the study record. This reflects an internal update to the record history display rather than changes to the study content.SummaryDifference0.1%

- Check81 days agoChange DetectedThe record history shows recruitment is closed to new participants, and the history reflects a new revision tag (v3.6.0) while the previous revision tag (v3.5.5) was removed.SummaryDifference0.3%

- Check88 days agoChange DetectedA newer revision tag (v3.5.5) was added to the page history and the previous tag (v3.5.4) was removed. This reflects an updated page version in the study record history.SummaryDifference0.1%

Stay in the know with updates to IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.